![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/05 | (2006.01) |
A61K 31/122 | (2013.01) | ||
A61K 31/122 | (2006.01) | ||
A61K 31/05 | (2013.01) | ||
A61P 25/28 | (2006.01) | ||
A61P 25/28 | (2018.01) |
(11) | Number of the document | 3866772 |
(13) | Kind of document | T |
(96) | European patent application number | 19801443.3 |
Date of filing the European patent application | 2019-10-17 | |
(97) | Date of publication of the European application | 2021-08-25 |
(45) | Date of publication and mention of the grant of the patent | 2023-10-11 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2019/056836 |
Date | 2019-10-17 |
(87) | Number | WO 2020/081879 |
Date | 2020-04-23 |
(30) | Number | Date | Country code |
201862747080 P | 2018-10-17 | US | |
201862771570 P | 2018-11-26 | US |
(72) |
HINMAN, Andrew W. , US
HOLST, Charles R. , US
MINELLA, Angela , US
MOLLARD, Paul , US
PINTCHOVSKI, Sean , US
TRIMMER, Jeffrey K. , US
TORREY, Eric , CA
|
(73) |
PTC Therapeutics, Inc. ,
100 Corporate Court
Middlesex Business Center, South Plainfield, New Jersey 07080,
US
|
(54) | 2,3,5-TRIMETHYL-6-NONYLCYCLOHEXA-2,5-DIENE-1,4-DIONE FOR SUPPRESSING AND TREATING ALPHA-SYNUCLEINOPATHIES, TAUOPATHIES, AND OTHER DISORDERS |
2,3,5-TRIMETHYL-6-NONYLCYCLOHEXA-2,5-DIENE-1,4-DIONE FOR SUPPRESSING AND TREATING ALPHA-SYNUCLEINOPATHIES, TAUOPATHIES, AND OTHER DISORDERS |